Synergetic B-cell Immunomodulation in SLE - 2nd Study.

NCT03747159 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Lupus Erythematosus, Systemic

Interventions

DRUG: Belimumab Injection

Sponsor

Leiden University Medical Center

Collaborators

[object Object]
[object Object]